Tricia Kuhl

Blake, Cassels & Graydon LLP


Tricia advises Canadian and international businesses on mergers and acquisitions, divestitures, private equity investments, corporate reorganizations, joint ventures, strategic alliances and a variety of commercial transactions. She has a particular focus in the life sciences, technology, cannabis, food & beverage and cosmetic industries.

Tricia has in-depth experience in the pharmaceutical industry, having worked at three large pharmaceutical companies on secondment earlier in her career. Prior to joining Blakes, she also worked at a publicly listed biotech company in Paris. She regularly negotiates and drafts clinical trial, research & development, manufacturing, supply, marketing, distribution, quality assurance, product listing and intellectual property assignment, transfer, license and commercialization agreements.

As the lead of the Cannabis group in the Montreal office, Tricia advises clients in the medical and recreational cannabis industry, including licensed producers, processors, applicants, research teams, product developers, online publishers and equipment manufacturers, on a variety of regulatory, corporate and commercial matters ranging from mergers and acquisitions, processing, licensing and import/export arrangements, manufacturing and supply deals and marketing guidelines and shareholder and partnership agreements. She also provides legal risk assessments to financial and strategic investors in the cannabis industry.

Tricia is fluent in English and in French and is both a Canadian and French Citizen.